Yahoo Suche Web Suche

Suchergebnisse

  1. Suchergebnisse:
  1. Vor 4 Stunden · In the TRAILBLAZER-ALZ 2 trial, people were able to complete treatment and switch to placebo at 6, 12, or 18 months after they achieved one of the study's treatment goals, minimal levels of ...

  2. Vor 22 Stunden · Placebo connait un succès commercial avec des albums emblématiques tels que Without You I’m Nothing (1998), Black Market Music (2000) et Meds (2006). Le groupe a acquis une réputation pour ses performances énergiques sur scène et son esthétique visuelle provocante. Avec plus de 3,5 millions d’auditeurs mensuels sur Spotify et des sons écoutés plus de 150 millions de fois, Placebo ...

  3. Vor 4 Stunden · Compared with patients who received only a placebo, Eli Lilly said those who got the drug saw their decline slow by up to 22% at 76 weeks after first starting the donanemab infusions. "Importantly ...

    • 6 Min.
    • Alexander Tin
  4. Vor 22 Stunden · 02.07.2024 - Trial met primary endpoint with statistical significance, with 71% of myasthenia gravis patients treated with Descartes-08 observed to have a clinically meaningful improvement in MGC ...

  5. Vor 16 Stunden · The author explores the initial excitement and subsequent skepticism regarding psychedelic therapy. They discuss the limitations in existing empirical evidence and stress the importance of cautious evaluation. Despite the current challenges in understanding psychedelics' therapeutic mechanisms, ongoing research at Leiden University continues to investigate their potential.

  6. Vor 22 Stunden · Annovis Bio (NYSE: ANVS) stock closed up a staggering 76% today on promising new data from its Phase 3 clinical study of its Parkinson’s treatment, buntanetap. Early results show that its ...

  7. Vor 2 Stunden · The U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early Alzheimer's, making it the second therapy for slowing progression of the brain-wasting disease that will ...